Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 1 6Phase 3 4Phase 1/2 3Phase NA 2

Status

Active not recruiting 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 4INDUSTRY 4NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 4

Conditions

Leukemia, Myeloid, Acute 4

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 183Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × OTHER × gilteritinib × Clear all
NCT07407140 2026-03-25

VAG-3+7-G

Institute of Hematology & Blood Diseases Hospital, China

Phase 3 Not yet recruiting
300 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07463651 2026-03-20

TROPHY-15

The First Affiliated Hospital of Soochow University

Phase 3 Recruiting
594 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04027309 2024-12-17

HOVON 156 AML

Stichting Hemato-Oncologie voor Volwassenen Nederland

Phase 3 Active not recruiting
777 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05177731 2024-10-03

Venetoclax + Decitabine vs. "7+3" Induction Chemotherapy in Young AML

The First Affiliated Hospital of Soochow University

Phase 3 Active not recruiting
188 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡